| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 276.96K | 6.87K | 102.54K | 159.51K | 781.21K | 367.86K |
| Gross Profit | 172.49K | 10.53K | 25.27K | 72.37K | 386.56K | 127.70K |
| EBITDA | -3.90M | -2.73M | -1.98M | -2.45M | -1.97M | -1.67M |
| Net Income | -4.87M | -2.85M | -2.16M | -2.67M | -2.32M | -1.76M |
Balance Sheet | ||||||
| Total Assets | 13.81M | 1.32M | 513.00K | 427.33K | 2.75M | 1.79M |
| Cash, Cash Equivalents and Short-Term Investments | 2.08M | 498.30K | 73.07K | 248.14K | 2.01M | 1.15M |
| Total Debt | 210.51K | 126.33K | 225.26K | 300.00K | 986.68K | 333.78K |
| Total Liabilities | 851.46K | 983.58K | 622.40K | 700.75K | 1.17M | 579.78K |
| Stockholders Equity | 13.07M | 374.94K | -109.41K | -273.41K | 1.58M | 1.21M |
Cash Flow | ||||||
| Free Cash Flow | -3.17M | -2.10M | -2.01M | -2.82M | -2.04M | -2.27M |
| Operating Cash Flow | -3.17M | -2.10M | -2.01M | -2.82M | -2.04M | -2.25M |
| Investing Cash Flow | -399.83K | -258.66K | 0.00 | 0.00 | 0.00 | -20.91K |
| Financing Cash Flow | 6.14M | 2.53M | 1.83M | 142.12K | 2.91M | 1.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | AU$98.71M | ― | ― | ― | ― | ― | |
48 Neutral | AU$30.75M | -102.50 | -3.14% | ― | 2.98% | 93.55% | |
48 Neutral | AU$26.12M | -3.97 | -31.01% | ― | -3.43% | -40.65% | |
44 Neutral | AU$31.91M | -14.50 | ― | ― | 7.32% | 67.11% | |
38 Underperform | AU$25.53M | -5.45 | -135.50% | ― | -48.98% | -12.82% | |
37 Underperform | AU$914.19K | -0.17 | ― | ― | ― | ― |
Nanoveu Ltd has applied to the ASX for quotation of 6,026,923 new fully paid ordinary shares, to be traded under its existing ticker NVU. The new securities, issued on 24 December 2025 following the exercise or conversion of existing options or other convertible instruments, will expand the company’s quoted share base and marginally increase its access to equity capital, with implications for existing shareholders’ dilution and market liquidity.
Nanoveu Limited has issued 6,026,923 new ordinary shares following the exercise of unlisted options, expanding its share capital without a separate disclosure document under Australia’s Corporations Act. The company confirmed it is compliant with its continuous disclosure and financial reporting obligations and that there is no excluded information, signalling a routine capital management move that modestly strengthens its equity base while maintaining regulatory transparency for investors.
Nanoveu Limited has announced an investor webinar to discuss the advancements of its subsidiary, EMASS, in ultra-low-power ECS-DoT system-on-chip (SoC) technologies. The webinar will highlight significant milestones such as the tape-out of a new integrated circuit on TSMC’s 16nm FinFET, collaborations with Arrow Electronics and Semtech, and the establishment of a sales network for ECS-DoT solutions. These developments are expected to enhance Nanoveu’s market positioning and offer scalable AI capabilities across various industries.
Nanoveu Limited’s subsidiary, Embedded A.I. Systems Pte. Ltd (EMASS), has reached a significant milestone with its 16nm ECS-DoT AIoT system-on-chip (SoC), completing the front-end, synthesis, and physical design stages. This development positions Nanoveu at the forefront of ultra-low-power Edge AI technology, integrating advanced features such as on-chip Bluetooth Low Energy, expanded on-chip memory, and enhanced AI acceleration, which collectively promise to improve energy efficiency and reduce costs for connected devices.
Nanoveu Limited announced an amendment to its previous ASX announcement regarding its collaboration with EMASS and Semtech on low-power edge AI. The amendment involved the removal of an incorrectly displayed Semtech logo, with no new material information affecting the release. This collaboration enhances Nanoveu’s portfolio, positioning it as a key player in the rapidly growing 3D content, AI, and edge computing markets.
Nanoveu Limited has announced that Michael Winlo has ceased to be a director of the company as of December 1, 2025. This change results in the automatic lapse of 2,500,000 Performance Rights previously held by Mr. Winlo, leaving him with no direct or indirect interest in the company’s Performance Rights. This development may impact the company’s governance structure and could have implications for its strategic direction.
Nanoveu Ltd. has announced the appointment of Mohamed Sabry Aly as a director, effective December 1, 2025. As part of his engagement, the company has agreed to issue him 5,000,000 performance rights, contingent upon the company achieving certain stock price milestones. This appointment and the associated performance rights reflect Nanoveu’s strategic focus on strengthening its leadership team to drive future growth and achieve market objectives.
Nanoveu Limited has announced the appointment of Professor Mohamed Sabry Aly and Mr. Raymond Chen as directors, effective December 1, 2025. Professor Aly, a non-independent non-executive director, brings significant technical expertise from his work in embedded AI and semiconductor technologies, while Mr. Chen, the current CFO, adds extensive financial and corporate experience. These appointments are part of Nanoveu’s strategic growth initiatives as the company seeks to enhance its leadership and pursue collaborations with global corporations. The company is also searching for additional strategic advisors to support its growth in edge-AI, IoT, drone, and semiconductor technologies.
Nanoveu Limited has achieved significant milestones in its edge-AI initiatives, including a 60% increase in drone flight time through ultra-low-power AI control and advancements in its 16nm chip development. The company has expanded its U.S. sales network and completed a dual listing on the OTCQB, enhancing its North American market access. Strategic funding has been secured to support these initiatives, positioning Nanoveu for further commercial growth and strengthening its leadership in edge-AI innovation.
Nanoveu Ltd. has announced the issuance of 4,500,000 fully paid ordinary shares, which will be quoted on the Australian Securities Exchange (ASX) under the code NVU. This move is part of the company’s strategy to leverage convertible securities, potentially enhancing its capital structure and market presence.
Nanoveu Limited has issued 4,500,000 ordinary shares following the exercise of unlisted options, as announced in compliance with the Corporations Act. The company is in preliminary discussions with a third party regarding potential distribution arrangements for its EyeFly3D products, although no binding agreements have been made. This development could impact Nanoveu’s market positioning and stakeholder interests, particularly in the 3D content and visualization sectors.